Q4 2016 Holdings
Filed 2017-02-14 | 77 holdings | $88.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cellectar Biosciences Inc | *W EXP 08/20/201 | 15117F120 | $10 | 52,999 | 0.0% |
| Cellectar Biosciences Inc | COM | 15117F302 | $65 | 53,649 | 0.0% |
| Oncobiologics Inc | *W EXP 02/18/201 | 68235M113 | $79 | 416,666 | 0.0% |
| Applied Genetic Technologies(2GT) | COM | 03820J100 | $162 | 17,321 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $296 | 50,613 | 0.0% |
| Oncobiologics Inc - Cw17 | *W EXP 05/18/201 | 68235M121 | $329 | 416,666 | 0.0% |
| Threshold Pharmaceutical Inc | COM NEW | 885807206 | $446 | 1,012,255 | 0.0% |
| HTG Molecular Diagnostics in | COM | 40434H104 | $456 | 203,464 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $587 | 1,087,715 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $903 | 40,490 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $1.2K | 100,000 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $1.4K | 990,579 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.7K | 240,403 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $1.8K | 287,031 | 0.0% |
| Tigenix | SPONSORED ADS | 88675R109 | $1.9K | 129,032 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $1.9K | 159,513 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $2.0K | 650,000 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $2.4K | 432,990 | 0.0% |
| Avexis Inc | COM | 05366U100 | $2.4K | 49,991 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $2.4K | 500,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $2.5K | 151,838 | 0.0% |
| Oncobiologics Inc | COM | 68235M105 | $2.5K | 833,333 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $2.6K | 100,000 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $2.8K | 751,296 | 0.0% |
| Catabasis Pharmaceuticals in | COM | 14875P107 | $2.9K | 800,000 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.9K | 156,741 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $3.2K | 563,880 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $3.3K | 127,451 | 0.0% |
| Advanced Accelerator Applic | SPONSORED ADS | 00790T100 | $3.3K | 124,220 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $3.6K | 1,000,000 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $4.4K | 767,466 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $4.6K | 809,804 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $4.9K | 603,000 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $5.1K | 339,175 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $5.2K | 172,083 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.4K | 90,000 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $5.5K | 538,422 | 0.0% |
| Pfenex Inc | COM | 717071104 | $5.7K | 632,559 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $5.9K | 1,421,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $6.7K | 3,842,966 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $6.8K | 2,868,700 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $7.1K | 900,000 | 0.0% |
| Curis Inc | COM | 231269101 | $7.4K | 2,410,900 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $7.5K | 480,501 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.8K | 110,842 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $8.2K | 449,660 | 0.0% |
| Synergy Pharmaceuticals del | COM NEW | 871639308 | $9.1K | 1,500,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $9.4K | 1,909,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $9.7K | 975,000 | 0.0% |
| Fulgent Genetics Inc(FLGT) | COM | 359664109 | $9.9K | 857,663 | 0.0% |